← SEC 公告列表 | UVE SEC 公告 | 環球保險控股公司(UVE)

重大事件 即時報告 8-K 2026-06-18

Universal Insurance Holdings發

於 SEC 網站開啟原文

AI 繁中摘要

Universal Insurance Holdings, Inc.(UVE)於2026年6月16日提交8-K表格,披露多項重要融資安排。 公司與合資格機構買家訂立票據購買協議,私募發行1億美元(USD)7.75%優先無擔保票據,2031年6月30日到期。淨收益將用於一般企業用途,包括贖回其未償還的5.625%優先票據(2026年到期)。相關交易已完成,公司已於6月17日全數贖回2026年票據,贖回價格為本金100%另加截至贖回日的應計未付利息。 新票據條要點如下: - 利率:年息7.75%,如獲評級機構調降或調升評級,利率將相應調整。 - 付息:每年6月30日及12月30日支付,首次於2026年12月30日。 - 提前贖回:2029年6月30日前,公司可按本金100%加適用溢價贖回;其後至2030年6月30日,贖回價為101.9375%;之後為100%。 - 持有人無權要求贖回,亦不可轉換為其他證券。 財務契約重點: - 公司須維持現金水平至少相等於未來12個月票據利息。 - 總合併負債與總合併GAAP資本化比率不得超過40%(按季度計算)。 - 有擔保負債(連同現有擔保負債)不得超過公司總合併負債的40%。 - 須盡合理努力維持票據評級。 違約事件發生時,公司義務可能加速到期,且在違約持續期間不得向股東派發現金股息。 本次發行依賴美國《證券法》第4(a)(2)條及Regulation D第506(b)條豁免註冊。公司同時簽訂註冊權協議,承諾提供交換要約,將票據換為經註冊的同等條款票據;若未履行義務,需支付額外利息。 對投資者的潛在影響:此舉以較高利率的長期債務(7.75%,2031年到期)取代較低利率的短期債務(5.625%,2026年到期),即時增加利息開支,但延長債務到期結構,改善流動性。財務契約對資產負債表槓桿及現金儲備施加限制,短期內或限制股息及資本配置彈性。投資者需關注公司未來盈利能力能否覆蓋新增利息成本,以及維持評級的能力。
展開英文正文
8-K

 false 0000891166 0000891166 2026-06-16 2026-06-16 
  
  
 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, DC 20549
  
  

 FORM 8-K
  
  

 CURRENT REPORT
 PURSUANT TO SECTION 13 OR 15(d)
 OF THE SECURITIES EXCHANGE ACT OF 1934
 Date of Report (Date of earliest event reported): June 16, 2026
  
  

  
 

 Universal Insurance Holdings, Inc. 
 (Exact name of registrant as specified in its charter)
  
  

  

Delaware
 
001-33251
 
65-0231984

 (State or other jurisdiction
 of incorporation)

 
 (Commission
 File Number)

 
 (IRS Employer
 Identification No.)

 1110 W. Commercial Blvd., Fort Lauderdale, Florida 33309
 (Address of Principal Executive Offices) (Zip Code)
 Registrant’s telephone number, including area code: (954) 958-1200
  
  

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  

☐
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  

☐
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  

☐
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  

☐
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:
  

 Title of each class

 
 Trading
 Symbol(s)

 
 Name of each exchange
 on which registered

Common Stock, $0.01 Par Value
 
UVE
 
New York Stock Exchange
 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 Emerging growth company ☐
 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
  
  
  

 

Item 1.01
 Entry into a Material Definitive Agreement. 

 On June 16, 2026, Universal Insurance Holdings, Inc. (the “Company”) entered into Note Purchase Agreements (the “Purchase Agreements”) with certain institutional accredited investors and qualified institutional buyers (collectively, the “Purchasers”) pursuant to which the Company issued and sold $100 million of 7.75% Senior Unsecured Notes due 2031 (the “2031 Notes”). The Purchase Agreements contain certain customary representations, warranties and covenants made by the Company, on the one hand, and the Purchasers, severally and not jointly, on the other hand. The Company intends to use the net proceeds from the Private Placement for general corporate purposes, including the redemption of its outstanding 5.625% Senior Notes due 2026 (the “2026 Notes”). 
 The 2031 Notes were offered and sold by the Company in a private placement transaction in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D thereunder. On June 16, 2026, in connection with the issuance and sale of the 2031 Notes, the Company entered into Registration Rights Agreements (the “Registration Rights Agreements”) with the Purchasers. Under the terms of the Registration Rights Agreements, the Company has agreed to take certain actions to provide for the exchange of the 2031 Notes for notes that are registered under the Securities Act and have substantially the same terms as the 2031 Notes (the “Exchange Offer”). Under certain circumstances, if the Company fails to meet its obligations under the Registration Rights Agreements, it would be required to pay additional interest to the holders of the 2031 Notes. 
 On June 16, 2026, the Company entered into an indenture, relating to the issuance of the 2031 Notes (the “Indenture”), by and between the Company and UMB Bank National Association, as trustee (the “Trustee”). The 2031 Notes are not subject to any sinking fund and are not convertible into or exchangeable, other than pursuant to the Exchange Offer, for any other securities or assets of the Company or any of its subsidiaries. The 2031 Notes are not subject to redemption at the option of the holder. At any time and from time to time prior to June 30, 2029, the Company may, at its option, redeem all or a portion of the 2031 Notes at a redemption price equal to 100.0% of the principal amount thereof plus the Applicable Premium (as defined in the Indenture) plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after June 30, 2029, the Company may redeem all or part of the 2031 Notes at redemption prices (expressed as percentages of the principal amount) equal to (i) 101.9375% for the twelve-month period beginning on June 30, 2029 to but excluding June 30, 2030 and (ii) 100.0% at any time thereafter, plus accrued and unpaid interest up to, but not including, the redemption date. 
 The 2031 Notes bear interest at a rate of 7.75% per annum, subject to adjustment from time to time in the event of a downgrade or subsequent upgrade of the rating assigned to the 2031 Notes. Interest on the 2031 Notes will be payable by the Company on June 30 and December 30 of each year, beginning on December 30, 2026. The 2031 Notes mature on June 30, 2031. 
 The Indenture contains certain financial covenants, including: 
  

 
•
 
 the Company shall maintain cash on hand at least equal to the next twelve months of interest payments on the Notes so long as the Notes remain outstanding; 

  

 
•
 
 the Company must maintain Total Consolidated Indebtedness to Total Consolidated GAAP Capitalization (as these terms are defined in the Indenture) less than or equal to 40%, as of the end of each calendar quarter; 

  

 
•
 
 other than existing secured indebtedness of the Company or any of its subsidiaries, the Company will not incur or permit to exist any mortgage, pledge, encumbrance or lien or charge securing indebtedness on any property or asset of the Company or any of its subsidiaries in excess of 40% of the Total Consolidated Indebtedness of the Company, when combined with any existing secured indebtedness of the Company or any of its subsidiaries; and 

  

 
•
 
 the Company will use reasonable best efforts to maintain a rating of the 2031 Notes from Kroll Bond Agency, LLC or any other “nationally recognized statistical rating organization” as defined under the Securities Act. 

 The Indenture contains events of default, the occurrence of which may result in the acceleration of the Company’s obligations under the 2031 Notes in certain circumstances. Upon an event of default and for as long as such event of default remains outstanding, the Company will not declare or pay any cash dividends to its stockholders. 
 The 2031 Notes are unsecured senior obligations of the Company, are not obligations of, and are not guaranteed by, any subsidiary of the Company. 
 The form of the Note Purchase Agreements and the Registration Rights Agreements are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and the description of the material terms of the Note Purchase Agreements and the Registration Rights Agreements, respectively, are qualified in their entirety by reference to such exhibits, which are incorporated herein by reference. The Indenture is filed as Exhibit 4.1 to this Current Report on Form 8-K and the description of the material terms of the Indenture is qualified in its entirety by reference to such exhibit, which is incorporated herein by reference. 

 

Item 2.03
 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. 

 The information set forth in Item 1.01 above is incorporated herein by reference. 
  

Item 8.01
 Other Events. 

 On June 11, 2026, the Company issued a notice of conditional redemption for all outstanding principal amount of the 2026 Notes under the indenture dated as of November 23, 2021, as amended, between the Company and the Trustee. The redemption was conditioned on the Company completing the private placement described in Item 1.01 above, which the Company completed on June 16, 2026. On June 17, 2026, the Company redeemed all of the outstanding 2026 Notes at a redemption price of 100.0% of their principal amount, plus accrued and unpaid interest to, but excluding, the redemption date. 
  

Item 9.01
 Financial Statements and Exhibits. 

 (d) Exhibits: 
  

Exhibit Number
  
 Description

4.1
  
Indenture, dated June 16, 2026. 

4.2
  
Form of 7.75% Senior Unsecured Notes due 2031 (included in Exhibit 4.1). 

10.1
  
Form of Note Purchase Agreement, dated June 16, 2026. 

10.2
  
Form of Registration Rights Agreement, dated June 16, 2026. 

104
  
The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101).

  

 

 SIGNATURES 
 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 
  

Date: June 18, 2026
 
UNIVERSAL INSURANCE HOLDINGS, INC.

 

 
By:
 
 /s/ Frank C. Wilcox

 

 
Name:
 
Frank C. Wilcox

 

 
Title:
 
Chief Financial Officer